Diseases, Conditions, Syndromes

Durability of bivalent boosters against omicron subvariants

New research led by the UNC Gillings School of Global Public Health shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.

Immunology

Keeping COVID-19 in check will likely require periodic boosters

Between natural infection and a global vaccination campaign, most people now have some immunity against the virus that causes COVID-19. This widespread immunity hasn't stopped people from getting infected, but it has dampened ...

Vaccination

China approves first domestic mRNA vaccine for COVID-19

China has approved its first locally developed messenger RNA (mRNA) vaccine against COVID-19, its manufacturer said Wednesday, months after the relaxation of strict COVID-zero regulations sparked a surge in cases.

page 5 from 40